Comparison of content and degradation profile of captopril between preparations compounded with analytical and extra pure soluble starch reagents
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Poster
- By: LIN (Chang-Gung Memorial Hospital, Pharmacy, Tao-yuan, China Taiwan)
- Co-author(s): Deng (Chang-Gung Memorial Hospital, China Taiwan)
Tsai (Chang-Gung Memorial Hospital, TAO-YUAN, China Taiwan)
Microdose (1.25mg) Captopril therapy is commonly used and the drug is currently extemporaneously compounded in our hospital. Two kinds of starch, Analytical Reagent (AR) and Extra-pure Reagent (ER), are used in outpatient and inpatient formulations respectively. The purpose of this study was to determine the optimum amount and type of starch.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.